Mr Liam Kelly QC (Chairman)
Barrister in private practice.
Mr Liam Kelly graduated from the University of Queensland in 1988 with honours in English literature and in law. He was awarded the university medal for law. He was awarded the Rhodes Scholarship for Queensland in 1989 and attended Magdalen College at Oxford University from where he graduated in 1991 with a Bachelor of Civil Law. He commenced private practice as a barrister in Brisbane in 1992 and continues to practise at the bar as a Queen’s Counsel. His field of work is commercial litigation.
Ms Chris Went (Deputy CHAIRperson)
CEO of Greenslopes Private Hospital and Director of the GMRF Board
Chris Went was appointed to the position of CEO at Greenslopes Private Hospital on 11 December 2017. Ms Went was previously CEO at St Andrew’s Ipswich Private Hospital (also a member of the Ramsay Group).
Having completed her nursing training in 1992, Chris has post graduate qualifications in the clinical specialties of cardiology and emergency as well as business administration.
Chris has represented the private sector on the Queensland Clinical Senate for the past six years, was a member of the Department of Health Patient Safety Board for three years and has represented the Australian Private Hospitals Association on the Queensland Clinical Education and Training Council.
PROFESSOR SCOTT BELL
CEO, Translational Research Institute (TRI)
Professor Scott Bell is the Chief Executive of the Translational Research Institute and a Senior Physician of the Adult Cystic Fibrosis Centre at TPCH (>320 patients) where he has worked since 1996 in Brisbane. He leads the Lung Bacteria Laboratory at UQ’s Children’s Health Research Centre.
Scott has >250 peer reviewed publications and has received grant support >$22 million over the past 10 years. His research interests include the CF microbiology, acquisition pathways for human infection and has a long history of supporting multi-disciplinary research. He has been principal investigator on numerous pivotal CFTR modulator trials and is global principal investigator on a novel approach to combination therapies for CFTR correction. He has been the Editor-in-Chief of the Journal of Cystic Fibrosis since 2013.
Dr Amanda Dines
Deputy Executive Director Medical Services, Metro North Hospital and Health Service.
Dr Amanda Dines was appointed as the Deputy Executive Director Medical Services of Metro North Hospital and Health Service in May 2019.
She served as the Director of General Health Reserves in the Royal Australian Air Force from 2012 to 2015. Since 2014, she has also served as the Honorary Aide de Camp to the Governor General of Australia.
Dr Dines has been an Adjunct Associate Professor at the University of Queensland Medical School since 2018.
PROFESSOR STEPHEN GRAY
Professor of Finance at University of Queensland, Director at Frontier Economics
Stephen Gray has been a Professor of Finance at the University of Queensland since 2000, and a Director of advisory firm Frontier Economics since 2014.
He teaches a range of award and executive education courses in financial management, asset valuation, and corporate finance.
Stephen is an active consultant to industry on issues relating to valuation, cost of capital, and corporate financial strategy. He has acted as a consultant to many of Australia’s leading companies, government agencies, and regulatory bodies and has appeared as an independent expert in a number of court and tribunal proceedings.
Stephen has Honours degrees in Commerce and Law from the University of Queensland and a PhD in Financial Economics from Stanford University.
Professor John Horvarth
Strategic Medical Advisor, Ramsay Health Care
Professor John Horvath AO was appointed as Strategic Medical Advisor for Ramsay Health Care in 2016.
Professor Horvath served as Australia’s Chief Medical Officer between 2003 and 2009 and has served as Chair of the Health Committee on the National Health and Medical Research Council (NHMRC). He has been a Board member of the Garvan Institute, Health Workforce Australia and Crown Resorts Ltd, and most recently served as Principal Medical Consultant to the Department of Health and Ageing from 2009 till recently.
Before joining the Department of Health, Professor Horvath’s career included 30 years in clinical practice at the Royal Prince Alfred where he established a number of clinical services and as Director of the Renal and Transplant Services. He has been active in teaching and research; policy development and implementation of national strategies on behalf of governments. He has represented Australia’s interest with the World Health Organisation and was Deputy Chair of the WHO’s international cancer research institute based in Lyon, France. He was awarded an Officer in the Order of Australia in 2001.
Mr Rob Skoda
CEO, RSL Queensland.
Robert Skoda commenced his career as a Ground Defence Officer in the Royal Australian Air Force, is a current reservist and has deployed to Afghanistan, Middle East and Timor Leste. Robert has extensive domestic and international experience in the private sector, with a focus on risk for remote construction projects and operations management of professional services, and since 2016 has demonstrated commitment to the military family through growing and enhancing RSL Queensland services.